Baluran, Merlyn N.
HRN: 24-42-16 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/14/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/14/2024
07/20/2024
IV
4.5 G Now Then 2.25 G
Q8
Septic Shock
Waiting Final Action
Indication: Empiric Type of Infection: Disseminated Systemic Infection Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes